Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug–Drug Interaction with Antidepressants

por MacLeod, A. Kenneth, McLaughlin, Lesley A., Henderson, Colin J., Wolf, C. Roland
Publicado 2017

A Targeted in Vivo SILAC Approach for Quantification of Drug Metabolism Enzymes: Regulation by the Constitutive Androstane Receptor

por MacLeod, A. Kenneth, Zang, Tuo, Riches, Zoe, Henderson, Colin J., Wolf, C. Roland, Huang, Jeffrey T.-J.
Publicado 2013

An Enhanced In Vivo Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) Model for Quantification of Drug Metabolism Enzymes

por MacLeod, A. Kenneth, Fallon, Padraic G., Sharp, Sheila, Henderson, Colin J., Wolf, C. Roland, Huang, Jeffrey T.-J.
Publicado 2015

HDAC Inhibitors Increase NRF2-Signaling in Tumour Cells and Blunt the Efficacy of Co-Adminstered Cytotoxic Agents

por McMahon, Michael, Campbell, Kathryn H., MacLeod, A. Kenneth, McLaughlin, Lesley A., Henderson, Colin J., Wolf, C. Roland
Publicado 2014

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

por MacLeod, A Kenneth, Acosta-Jimenez, Lourdes, Coates, Philip J, McMahon, Michael, Carey, Frank A, Honda, Tadashi, Henderson, Colin J, Wolf, C Roland
Publicado 2016

Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer

por MacLeod, A Kenneth, Acosta-Jimenez, Lourdes, Coates, Philip J, McMahon, Michael, Carey, Frank A, Honda, Tadashi, Hayes, John D, Henderson, Colin J, Wolf, C Roland
Publicado 2017